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In Colombia, zosteriform leishmaniasis is a little-known and infrequent clinical variant of cutaneous 
leishmaniasis. Its clinical features include one or more plaques made up of papules and pseudo-vesicles, 
which conform to a lineal pattern, as well as satellite lesions that affect one or more dermatomes, 
without crossing the median line. 
We present three zosteriform cutaneous leishmaniasis cases in which Leishmania panamensis and 
Leishmania braziliensis were identified as the infective species. In light of the fact that the disease occurs 
infrequently, diagnosis was reached by taking into account epidemiological and clinical suspicion.
Key words: Leishmania, Leishmania braziliensis; leishmaniasis, cutaneous; herpes zoster, diagnosis, 
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Leishmaniasis cutánea zosteriforme causada por Leishmania (Viannia) panamensis y Leishmania 
(Viannia) braziliensis: reporte de tres casos
La leishmaniasis zosteriforme es una variante clínica de la leishmaniasis cutánea, infrecuente y poco 
conocida en Colombia. Clínicamente se caracteriza por una o varias placas conformadas por pápulas y 
pseudovesículas que siguen un patrón lineal, y por lesiones satelitales que comprometen uno o varios 
dermatomas sin sobrepasar la línea media. 
Se presentan tres casos de leishmaniasis cutánea zosteriforme en los que se identificaron Leishmania 
panamensis y Leishmania braziliensis como especies infectantes. La sospecha epidemiológica 
derivada de la procedencia de los pacientes, así como la sospecha clínica a partir del reconocimiento 
de una presentación infrecuente de la enfermedad, permitieron hacer el diagnóstico.
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diagnóstico, epidemiología.
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Leishmaniasis is an endemic disease in Colombia. 
A striking number of new cases has been reported 
in the past decade: up from 4,130 cases in the 
year 2001 to 9,684 cases in the year 2011. It 
accounts for 20% of all leishmaniasis cases 
registered in the Americas over the period 2001-
2011, and places the country second in incidence, 
surpassed only by Brazil (1). In Colombia, 98% of 
all cases are classified as cutaneous leishmaniasis 
(2), generally presenting as a papule or nodule on 
an exposed area that grows progressively and 
turns into a painless ulcer with infiltrated edges 
(3,4). Other clinical manifestations designated 
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as “atypical” because they are infrequent and 
little known may also occur. These are given 
different names according to the lesion´s clinical 
characteristics (annular, chancriform, cicatricial, 
keloid, tumoral, acneiform, panniculitis, verrucous), 
its similarity to other diseases (lupoid, acneiform, 
eczematous, erysipeloid, sporotrichoid, psoriasiform, 
rhinophymatous, mycetomatous, zosteriform) and 
the anatomical localization (palmoplantar, genital, 
conjunctival, whitlow, paronichial) (4-9).
Among the atypical cutaneous leishmaniasis 
manifestations, zosteriform is one of the least 
frequent, accounting for a scant number of reported 
cases in the Americas (10). Its global prevalence 
varies between 0.17% and 2.5%, according to 
some case series from the Middle East (6,11). It 
is clinically discernible by one or more plaques 
composed of papules or pseudo-vesicles, located 
on the head (10,12), back (8,9), abdomen (13) or 
lower limbs (7), forming a lineal pattern and satellite 
lesions that involve one or more dermatomes that do 
not cross the median line (6,8,12). The appearance 
and distribution of lesions can cause the disease to 
be confused with herpes zoster, thus complicating 
initial diagnosis. A biopsy may be ordered which, 
in turn, may make histological pattern identification 
difficult since it differs from that observed in typical 
lesions of cutaneous leishmaniasis. 
In the three cases described below cutaneous 
leishmaniasis diagnosis was confirmed using 
either microbiological or direct methods. In two 
cases, the etiological agent was identified using 
monoclonal antibodies, whereas in the case with 
biopsy sample (case 2), the species was identified 
using molecular methods.
Clinical cases
Case 1. A 21-year old male farmer, born in and 
resident of Falan (Department of Tolima), presented 
3 month-old slightly itchy lesions on the abdomen 
that had spread progressively, and for which he 
had received several cycles of oral antibiotics with 
no signs of improvement. Physical examination 
revealed on the abdomen numerous small 
infiltrated confluent papules with shiny surface, 
that formed five erythematous plaques distributed 
over dermatomes T8, T9 and T10 (figure 1). Direct 
smear exam and lesion aspirate culture tested 
positive for leishmaniasis. Leishmania panamensis 
was cultured and identified by means of species 
specific B4 and B11 monoclonal antibodies. This 
species is compatible with the reference strain 
MHOM/PA/71/LS94. Treatment was begun with 
meglumine antimoniate (Glucantime®) at a dosage 
of 20 mg/Kg per weight/day for 20 days, with 
subsequent lesion involution and healing.
Case 2. A 30-year old baker, born in and resident 
of Bogotá, presented asymptomatic lesions on 
the dorso-lumbar region with 2-month evolution, 
for which he had received various topical and oral 
acyclovir treatments with no signs of improve-
ment. Physical examination revealed a violet 
erythematous plaque on the right lumbar region 
over dermatomes L2, L3 and L4 that was composed 
of pseudo-vesicles and yellowish erythematous 
papules. Some of these were shiny and infiltrated, 
with slight scaling and a small central scab (figure 
2). Under the diagnostic impression of sarcoidosis, 
a skin biopsy was performed. Histologically, the 
epidermis showed discrete acanthosis with dense 
histiocytic-lymphocytic infiltrates throughout the 
dermis, suggesting the presence of a live agent 
Figure 1. Shiny, confluent papules forming brown erythematous 
plaques with lineal distribution on abdomen 
Figure 2. Violet erythematous plaque with numerous shiny 
and pseudovesicle papules on the lumbar region
342
Biomédica 2014;34:340-4Morales CA, Palacio J, Rodríguez G, Camargo YC
(figure 3A). The patient was interviewed once again 
and he mentioned that the lesions had appeared 
2 weeks after visiting Otanche (Department of 
Boyacá). Direct smear exam and lesion aspirate 
culture were ordered, the results of which resulted 
positive for leishmaniasis. In a later review of 
histological slides, numerous amastigotes were 
observed (figure 3B), and by means of molecular 
methods L. braziliensis was identified as the 
etiologic agent. Montenegro skin test results were 
also positive. Treatment began with meglumine 
antimoniate (Glucantime®) at a dosage of 20 mg/
Kg per weight/day for 20 days, with subsequent 
lesion involution and healing.
Case 3. A 27-year old male miner, born in and 
resident of Pacho (Department of Cundinamarca) 
underwent physical examination with a 1-month 
history of asymptomatic lesions on his back. Exam-
ination of the right infra-scapular region revealed a 
brown erythematous plaque, over dermatomes T5 
and T6 made up of papules and pseudo-vesicles, 
with a lineal distribution on its upper border (figure 
4). Direct smear exam and the culture of the 
lesion aspirate tested positive for leishmaniasis. 
Leishmania panamensis was identified by means of 
species specific B4 and B11 monoclonal antibodies. 
This species is compatible with the reference strain 
MHOM/PA/71/LS94. The patient was treated with 
meglumine antimoniate (Glucantime®) at a dosage 
of 20 mg/Kg per weight/day for 20 days, with 
subsequent lesion involution and healing.
Discussion
The clinical manifestations of cutaneous, mucosal or 
mucocutaneous and visceral leishmaniasis, depend 
upon the host´s immunological response and the 
virulence of the infecting strain. Therefore, the 
spectrum of the disease varies from asymptomatic 
cutaneous infection to visceral involvement, which 
is potentially mortal (14). In the Americas, 95.7% of 
the cases for which clinical information is available 
are classified as cutaneous leishmaniasis (1). In 
Colombia, 98% of leishmaniasis cases are cutaneous 
(2), and lesions are generally caused by species 
belonging to the subgenus Viannia: L. panamensis; 
L. braziliensis and L. guyanensis (15,16).
At the National Institute of Dermatology of 
Colombia, a referral dermatology center receiving 
patients from almost all regions of the country, most 
cutaneous leishmaniasis cases (92%), including 
those with atypical symptoms, are caused by L. 
Figure 3. A. Skin biopsy without epidermal hyperplasia and with dense histiocytic-lymphocytic superficial dermal infiltrates. 
Hematoxiline-eosin (HE), 10X. B. Presence of amastigotes. Hematoxiline-eosin (HE), 100X
A B
Figure 4. Brown erythematous plaque with papules and 
pseudovesicles with lineal distribution (upper edge) on the right 
infrascapular region
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panamensis (74.5%) (16). This species had been 
reported previously as the etiological agent of diffuse 
cutaneous leishmaniasis in an AIDS patient (16), 
and in three patients with disseminated, erysipeloid 
and leishmaniasis recidivans cutis (4). This contrasts 
with numerous reports on atypical cases from the 
Mediterranean basin (12) and from other countries, 
including Pakistan (5-7,11,13,17), India (18), Iran 
(8,9) and Lebanon (19), where the major infective 
species is L. major. In these publications, the 
clinical polymorphism of the disease has been 
related to parasite dependent factors, such as 
virulence of the species (5,6,8,9,18), the vector 
(12), and geographical region where infection 
took place (11,12,18), and to the host, such as 
lesion localization (5,8) and immune response 
(5-8,11,12,18).
In the three cases we present, lesions were 
localized on the trunk, on covered areas (table 1), 
which could suggest a relation between infection 
site and atypical clinical presentation due to 
anatomical and physiological variations related 
to aspects such as local immune response, skin 
temperature and microcirculation of the dermis 
where the parasite develops (20). The influence 
of anatomical site on the host´s clinical and 
immunological response has been studied in 
experimental animal models with L. panamensis, in 
which clear differences have been established for 
time of evolution, quantity of inflammatory infiltrate 
and tissue necrosis, parasite load, antibody produc-
tion and treatment response, depending on the 
site where inoculation took place (20).
It has also been suggested that in other atypical 
forms, such as erysipeloid leishmaniasis, parasite 
dissemination in the papillary dermis hinders the 
ability of the immune system to control the disease 
(12,21). Since the three patients in this series 
had numerous amastigotes, it is possible that the 
host´s deficient immune response, when faced 
with certain Leishmania species (L. panamensis 
and L. braziliensis in the New World and L. major in 
the Old World), allows for parasite replication and 
dissemination with a clinical pattern different from 
the typical one.
The difficulty of orienting clinical diagnosis in 
patients with atypical forms of cutaneous leish-
maniasis usually calls for a biopsy, which can also 
be confusing for the pathologist when it means 
dealing with non-ulcerated lesions due to the lack 
of epidermal hyperplasia. However, the presence 
of a diffuse dermal infiltrate rich in plasmocytes 
and vacuolated macrophages allows for diagnostic 
orientation and the careful search for the parasite in 
lesion biopsies of less than 2-to-3-month evolution. 
In these, it is possible to observe the amastigotes 
in more than 70% of cases (22). Another scenario 
where epidermal hyperplasia is seen is in the 
diffuse form of the disease where the epidermis can 
be atrophic but the dermal infiltrate has abundant 
vacuolated macrophages that phagocyte the large 
quantities of amastigotes present (23).
In addition to herpes zoster, the differential diag-
nosis in zosteriform leishmaniasis includes other 
infectious skin diseases such as lupus vulgar 
and late secondary syphilis; inflammatory ones 
such as tumid lupus erythematosus, granuloma 
annulare and cutaneous sarcoidosis; and tumoral 
ones such as B-cell cutaneous lymphoma, among 
other diseases. In one of the three cases (figure 2), 
lesions were confused with another granulomatous 
disease, and diagnosis was deferred until a history 
Table 1. Parasitological characteristics and epidemiological and clinical features of the three patients with zosteriform leishmaniasis
Case 1 Case 2 Case 3
Gender
Age
Place of origin
Altitude
Average temperature 
Lesion localization 
Lesion type
Evolution
Montenegro skin test
Direct test
Culture test
Infective species¹
Male
21
Falan, Tolima
990 m/ mamsl
27° C
Abdomen
Plaques and papules
3 months
5 x 5 mm (+)
Positive (1-5 amastigotes per 
microscopic field)
Positive
L. panamensis
Male
30
Otanche, Boyacá
1050 m/AMSL
23° C
Lumbar region
Plaques and papules
2 months
10 x 9 mm (+)
Positive (1-5 amastigotes per 
microscopic field)
Positive
L. braziliensis
Male
27
Pacho, Cundinamarca
2136 m/AMSL
19° C
Dorsal region
Plaques and papules
1 month
7 x 7 mm (+)
Positive (1-5 amastigotes per 
microscopic field)
Positive
L. panamensis
mamsl: meters above mean sea level 
¹ Identification by means of monoclonal antibodies in cases 1 and 3, and by PCR in case 2
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of visiting an endemic area of leishmaniasis was 
known (24). In the other cases, the epidemiological 
criteria and lesion recognition by an expert derma-
tologist allowed for disease suspicion, which was 
later confirmed by microbiological tests that also 
provided identification of the infective species 
(table 1).
In conclusion, zosteriform leishmaniasis in Colombia 
is an infrequent and little known variant of cuta-
neous leishmaniasis, which, like other atypical 
manifestations, could be related to the infective 
species and to the host´s immune response, among 
other factors, and can be confused with different 
dermatological diseases. 
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